Magnetic Resonance Imaging Combined With Venous Ultrasonography of the Legs for Pulmonary Embolism (IRM-EP2)
Pulmonary Embolism
About this trial
This is an interventional diagnostic trial for Pulmonary Embolism focused on measuring pulmonary embolism, magnetic resonance imaging, venous ultrasonography of the legs, diagnostic performances
Eligibility Criteria
Inclusion criteria :
- age > or = 18 years
- clinical suspicion of PE
- Affiliate (e) to a social security
- provide written informed consent
Exclusion criteria :
- Unstable patient clinically in shock on arrival at the emergency department
- Current pregnancy
- Life expectancy less than 3 months (eg terminal cancer)
- Follow up at 3 months impossible
- Anticoagulation curative> 48 hours prior to inclusion
- Cons-indication to spiral chest CT: allergy to contrast or creatinine clearance below 30 ml / min calculated by the Cockcroft
- Cons-indication to MRI claustrophobia, presence of intraocular metallic implant or a pacemaker, an allergy to gadolinium, morbid obesity (weight> 130 kg, anteroposterior> 60 cm diameter)
Sites / Locations
- Hôpital Européen Georges Pompidou
Arms of the Study
Arm 1
Experimental
Intervention
In case of positive D-dimer testing or in patients with a high clinical probability of PE, these patients have MRI protocol combined with venous ultrasonography of the legs. MRI includes 2 different sequences: Unenhanced steady-state-free precession sequences (SSFP) sequences and angiography sequences. (please see \\\"intervention section\\\" for more details). MRI readings will be performed centrally by two independent readers blinded to the results of diagnostic reference standard. Venous ultrasonography of the legs will be interpreted locally.